Prevalence of sarcopenia in older age hospitalized persons, as determined by different sets of diagnostic criteria
e202102033
Keywords:
Older age persons, Muscular Strength, Reference Standards, Sarcopenia, FrailtyAbstract
Background: Sarcopenia is a geriatric syndrome characterised by the progressive loss of skeletal muscle mass, muscular strength, and physical performance; it carries the risk of physical incapacity and reduced quality of life. This work reported the prevalence of sarcopenia in people aged ≥65 years, all in-patients at the Hospital Central de la Defensa Gómez Ulla, as determined by three sets of diagnostic criteria. The suitability of the indistinct use of these criteria sets was discussed.
Methods: This was a cross sectional study. Sarcopenia was diagnosed depending on muscle mass, strength and functionality according to the European Working Group on Sarcopenia in Older People (EWGSOP), EWSOP2 and SARCF criteria. This study involved 295 people, all aged ≥65 years, and all of whom had been admitted to the above hospital between 1st March and 30th September 2018. Sampling was consecutive and performed at the internal medicine ward.
Results: The overall prevalence of sarcopenia was 43.7% [95%CI 38-49.4%] according to the EWGSOP criteria, 28.5% [23.3-33.7%] according to EWGSOP2, and 37.6% [32-43.1%] according to SARCF. The EWGSOP criteria showed sarcopenia to be significantly more common among men than women (p<0.05).
Conclusions: The prevalence of sarcopenia recorded differed depending on the set of criteria used; they cannot, therefore, be used indistinctly for the diagnosis of this condition. Rather, given the results obtained, it would seem reasonable, in Europe, to continue using the EGSWOP criteria while research continues in this area.
Downloads
References
Yu R, Wong MLJ. Incidence, reversibility, risk factors and the protective Community-dwelling, effect of high body mass index against sarcopenia. Geriatr Gerontol Int. 2014;14:15–28.
Cruz Jentoft AlJ, Baeyens JPBJ, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková EVM. Age and ageing. 2010;44(10):412–23.
Cruz Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7.
Woo J. Sarcopenia. Clin Geriatr Med. 2017;33(3):305–14.
Cruz-Jentoft AJ, Bahot G, Bauer J, Boirie Y, Bruyere O, Cerder Holm T, Cooper C, Landi F, Rolland Y. Writing Group for the European Working Group for EWGSOP2. Age and Ageing 2019.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36.
Melton LJ, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM RB. Epidemiology of sarcopenia. J Am Geriatr Soc. 48:625–30.
Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 year. J Appl Physiol. 1985;89:81–8.
Lee SY, Gallagher D. Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care. 2008;11:566–72.
Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27:337–9.
Shaw SC, Dennison EM, Cooper C. Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse. Calcif Tissue Int. 2017;101(3):229–47.
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF. Sarcopenia among hospitalized patients - A cross-sectional study. Clin Nutr. 2015;34(6):1239–44.
DV C-M, Infante-Sierra H S-ZA. Sarcopenia y funcionalidad en el adulto mayor hospitalizado. Nutr Hosp. 2015;31(4):1660–6.
Chodzko-Zajko, Proctor D, Minson C, Salem JS SG. Exercise and Physical Activity for Older Adults. 2009.
Rolland Y, Lauwers-Cances V, Cournot M, Nourhashémi F, Reynish W, Rivière D et al. S. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003;51:1120–4.
American Society of Hand Therapists. Clinical Assessment Recommendations, 3rd Edition. 2016.
Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology. 2014;60(4):294–305.
Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014;43:748-759.
Rodríguez Rejón AI, Ruiz López RA. Diagnóstico y prevalencia de sarcopenia en residencias de mayores: EWGSOP2 frente al EWGSOP1. Nutr Hosp. 2020;36(5). Doi: http://dx.doi.org/10.20960/nh.02573
Chávez Moreno DV, Infante Sierra H, Serralde Zúñiga AE. Sarcopenia y funcionalidad en el adulto mayor hospitalizado. Nutr Hosp. 2015;31(4):1660–6.
Slezak SG, Mahoney KB, Renna EN, Lofgren IE, Xu F, Hatfield DL et al. Comparison Of Current Sarcopenia Classification Criteria In Older New England Women. J Aging Res Clin Pract. 2017;6(18):163–7.
Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A, Corica F et al. Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People : The GLISTEN Study. J Gerontol A Biol Sci Med Sci. 2017;72(11):1575–81.
Lardiés Sánchez B, Sanz París A, Pérez Nogueras J, Serrano Oliver A, Torres Anoro ME, Cruz Jentoft AJ. Influence of nutritional status in the diagnosis of sarcopenia in nursing home residents. Nutrition. 2017;41:51-57.
Lardiés Sánchez B, Sanz-París A, Boj-Carceller D, Cruz-Jentoft AJ. Systematic review: prevalence of sarcopenia in ageing people using bioelectrical impedance analysis to assess muscle mass. Eur Geriatr Med 2016;7:256–61.
Melton LJ, Khosla S, Crowson CS, O´Connor MK, O´Fallon WM, Riffs BL. Epidemiology of sarcopenia. J Am Getriatr Soc. 2000;48:625-630.
Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JW. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 2015;82:418.
Downloads
Published
Versions
- 2021-02-26 (2)
- 2021-02-26 (1)
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 María Julia Ajejas Bazán, Julia Wärnberg, Isabel Jiménez Trujillo, Silvia Domínguez Fernández, Rodrigo Jiménez García, Napoleón Pérez Farinós
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
